Variable Definition Table
The information provided in this table is also available in an ASCII text file (TXT, 5 KB) (semicolons are used as the delimiters).
To see how this variable is used with SEER data and the other lymphoma variable definition, see the Lymphoma Subtype Recode home page.
| Site Group | Grade | ICD-O-3 Primary Site | ICD-O-3 Histology | Recode |
|---|---|---|---|---|
| Lymphoid Neoplasm | ||||
| 1. Hodgkin Lymphoma | ||||
| 1(a). Classical Hodgkin lymphoma | ||||
| 1(a)1. Lymphocyte-rich/mixed cellularity/lymphocyte depleted | ||||
| 1(a)1.1. Lymphocyte-rich | 0-9 | C000-C809 | 9651 | 01 |
| 1(a)1.2. Mixed cellularity | 0-9 | C000-C809 | 9652 | 02 |
| 1(a)1.3. Lymphocyte-depleted | 0-9 | C000-C809 | 9653-9655 | 03 |
| 1(a)2. Nodular sclerosis | 0-9 | C000-C809 | 9663-9667 | 04 |
| 1(a)3. Classical Hodgkin lymphoma, NOS | 0-9 | C000-C809 | 9650, 9661-9662 | 05 |
| 1(b). Nodular lymphocyte predominant Hodgkin lymphoma | 0-9 | C000-C809 | 9659 | 06 |
| 2. Non-Hodgkin lymphoma | ||||
| 2(a). Non-Hodgkin lymphoma, B-cell | ||||
| 2(a)1. Precursor Non-Hodgkin lymphoma, B-cell | 0-9 | C000-C809 | 9728, 9811-9818, 9836 | 07 |
| 6 | C000-C809 | 9727, 9835 | 07 | |
| 2(a)2. Mature Non-Hodgkin lymphoma, B-cell | ||||
| 2(a)2.1. Chronic/Small/Prolymphocytic/Mantle B-cell NHL | ||||
| 2(a)2.1.1. Chronic/Small lymphocytic leuk/lymph | 0-9 | C000-C809 | 9670, 9823 | 08 |
| 2(a)2.1.2. Prolymphocytic leukemia, B-cell | 0-9 | C000-C809 | 9833 | 09 |
| 6 | C000-C809 | 9832 | 09 | |
| 2(a)2.1.3. Mantle-cell lymphoma | 0-9 | C000-C809 | 9673 | 10 |
| 2(a)2.2. Lymphoplasmacytic lymphoma/Waldenstrom | ||||
| 2(a)2.2.1. Lymphoplasmacytic lymphoma | 0-9 | C000-C809 | 9671 | 11 |
| 2(a)2.2.2. Waldenstrom macroglubulinemia | 0-9 | C000-C809 | 9761 | 12 |
| 2(a)2.3. Diffuse large B-cell lymphoma (DLBCL) | ||||
| 2(a)2.3.1. DLBCL, NOS | 0-9 | C000-C498, C500-C809 | 9680, 9688, 9737-9738 | 13 |
| 6 | C000-C809 | 9684, 9735 | 13 | |
| 2(a)2.3.2. Intravascular large B-cell lymphoma | 0-9 | C499 | 9680, 9688, 9737-9738 | 14 |
| 0-9 | C000-C809 | 9712 | 14 | |
| 2(a)2.3.3. Primary effusion lymphoma | 0-9 | C000-C809 | 9678 | 15 |
| 2(a)2.3.4. Mediastinal large B-cell lymphoma | 0-9 | C000-C809 | 9679 | 16 |
| 2(a)2.4. Burkitt lymphoma/leukemia | 0-9 | C000-C809 | 9687, 9826 | 17 |
| 2(a)2.5. Marginal-zone lymphoma (MZL) | ||||
| 2(a)2.5.1. Splenic MZL | 0-9 | C000-C809 | 9689 | 18 |
| 2(a)2.5.2. Extranodal MZL, MALT type | 0-9 | C000-C769, C780-C809 | 9699 | 19 |
| 0-9 | C000-C809 | 9760, 9764 | 19 | |
| 2(a)2.5.3. Nodal MZL | 0-9 | C770-C779 | 9699 | 20 |
| 2(a)2.6. Follicular lymphoma | 0-9 | C000-C809 | 9690-9691, 9695, 9698 | 21 |
| 2(a)2.7. Hairy-cell leukemia | 0-9 | C000-C809 | 9940 | 22 |
| 2(a)2.8. Plasma cell neoplasms | ||||
| 2(a)2.8.1. Plasmacytoma | 0-9 | C000-C809 | 9731, 9734 | 23 |
| 2(a)2.8.2. Multiple myeloma/plasma-cell leuk. | 0-9 | C000-C809 | 9732-9733 | 24 |
| 2(a)2.9. Heavy chain disease | 0-9 | C000-C809 | 9762 | 25 |
| 2(a)3. Non-Hodgkin lymphoma, B-cell, NOS | 6 | C000-C809 | 9591, 9675 | 26 |
| 2(b). Non-Hodgkin lymphoma, T-cell | ||||
| 2(b)1. Precursor Non-Hodgkin lymphoma, T-cell | 0-9 | C000-C809 | 9729 | 27 |
| 5, 7, 8 | C000-C809 | 9727, 9835 | 27 | |
| 2(b)2. Mature Non-Hodgkin lymphoma, T-cell | ||||
| 2(b)2.1. Mycosis fungoides/Sezary syndrome | ||||
| 2(b)2.1.1. Mycosis fungoides | 0-9 | C000-C809 | 9700 | 28 |
| 2(b)2.1.2 Sezary syndrome | 0-9 | C000-C809 | 9701 | 29 |
| 2(b)2.2. Peripheral T-cell lymphoma | ||||
| 2(b)2.2.1. Peripheral T-cell lymphoma, NOS | 0-9 | C000-C809 | 9702 | 30 |
| 5, 7, 8 | C000-C809 | 9675 | 30 | |
| 2(b)2.2.2. Angioimmunoblastic T-cell lymphoma | 0-9 | C000-C809 | 9705 | 31 |
| 2(b)2.2.3. Subcutaneous panniculitis-like T-cell lymphoma | 0-9 | C000-C809 | 9708 | 32 |
| 2(b)2.2.4. Anaplastic large cell lymphoma, T- or Null-cell | 0-9 | C000-C809 | 9714 | 33 |
| 2(b)2.2.5. Hepatosplenic T-cell lymphoma | 0-9 | C000-C809 | 9716 | 34 |
| 2(b)2.2.6. Enteropathy-type T-cell lymphoma | 0-9 | C000-C809 | 9717 | 35 |
| 2(b)2.2.7. Cutaneous T-cell lymphoma, NOS | 0-9 | C000-C809 | 9709, 9726 | 36 |
| 2(b)2.2.8. Primary cutaneous anaplastic large cell lymphoma | 0-9 | C000-C809 | 9718 | 37 |
| 2(b)2.3. Adult T-cell leukemia/lymphoma | 0-9 | C000-C809 | 9827, 9837 | 38 |
| 2(b)2.4. NK/T-cell lymph., nasal-type/aggressive NK leuk. | 0-9 | C000-C809 | 9719, 9948 | 39 |
| 2(b)2.5. T-cell large granular lymphocytic leukemia | 0-9 | C000-C809 | 9831 | 40 |
| 2(b)2.6. Prolymphocytic leukemia, T-cell | 0-9 | C000-C809 | 9834 | 41 |
| 5, 7, 8 | C000-C809 | 9832 | 41 | |
| 2(b)3. Non-Hodgkin lymphoma, NOS, T-cell | 5, 7, 8 | C000-C809 | 9591, 9684, 9735 | 42 |
| 2(c). Non-Hodgkin lymphoma, unknown lineage | ||||
| 2(c)1. Precursor lymphoblastic leuk/lymph, unknown lineage | 1-4, 9 | C000-C809 | 9727, 9835 | 43 |
| 2(c)2. Prolymphocytic leukemia, unknown lineage | 1-4, 9 | C000-C809 | 9832 | 44 |
| 2(c)3. Non-Hodgkin lymphoma, NOS, unknown lineage | 1-4, 9 | C000-C809 | 9591, 9597, 9675, 9684, 9735 | 45 |
| 3. Composite Hodgkin lymphoma and NHL | 0-9 | C000-C809 | 9596 | 46 |
| 4. Lymphoid neoplasm, NOS | 0-9 | C000-C809 | 9590, 9594, 9724-9725, 9820, 9970-9971 | 47 |
* This table was updated for Hematopoietic codes based on WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008).
^ Subject to change based on evolving ICD-O-3 coding rules.
